Skip to content
Home/Companies/HealthTech/Talkiatry
Talkiatry

Talkiatry

HealthTech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Talkiatry?

Talkiatry is a French HealthTech company, currently owned by Blisce since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Blisce
Investor
Blisce
Blisce Fund II · 2023 · VC

Key facts

HQFrance
SectorHealthTech
Websitewww.talkiatry.com

More from Blisce Fund II

Other portfolio companies in the same fund.

Almetra (Deltia)
Almetra (Deltia)
Active
AI/MLGermany· 2026
Ami Labs
Active
AI/MLFrance· 2026
evroc
evroc
Active
Cloud InfrastructureSweden· 2024
Reforest'Action
Reforest'Action
Active
ClimateTechFrance· 2024
Local Infusion
Local Infusion
Active
HealthcareUS· 2023
Too Good To Go
Active
FoodTechDenmark· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Talkiatry?

Talkiatry is currently owned by Blisce, through Blisce Fund II, since 2023.

When did Blisce acquire Talkiatry?

Blisce acquired Talkiatry in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue